Lawerman Tjitske F, Brandsma Rick, van Geffen Joke T, Lunsing Roelineke J, Burger Huibert, Tijssen Marina A J, de Vries Jeroen J, de Koning Tom J, Sival Deborah A
Department of Neurology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
General Practice, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Dev Med Child Neurol. 2016 Jan;58(1):70-6. doi: 10.1111/dmcn.12804. Epub 2015 May 21.
To investigate the interobserver agreement on phenotypic early-onset ataxia (EOA) assessment and to explore whether the Scale for Assessment and Rating of Ataxia (SARA) could provide a supportive marker.
Seven movement disorder specialists provided independent phenotypic assessments of potentially ataxic motor behaviour in 40 patients (mean age 15y [range 5-34]; data derived from University Medical Center Groningen medical records 1998-2012). We determined interobserver agreement by Fleiss' kappa. Furthermore, we compared percentage SARA subscores ([subscore/total score]×100%) between 'indisputable' (primary ataxia recognition by at least six observers) and 'mixed' (ataxia recognition, unfulfilling 'indisputable' criteria) EOA phenotypes.
Agreement on phenotypic EOA assessment was statistically significant (p<0.001), but of moderate strength (Fleiss' kappa=0.45; 95% CI 0.38-0.51). During mild disease progression, percentage SARA gait subscores discriminated between 'indisputable' and 'mixed' EOA phenotypes. In patients with percentage SARA gait subscores >30%, primary ataxia was more frequently present than in those with subscores <30% (p=0.001).
Among movement-disorder professionals from different disciplines, interobserver agreement on phenotypic EOA recognition is of limited strength. SARA gait subscores can provide a supportive discriminative marker between EOA phenotypes. Hopefully, future phenotypic insight will contribute to the inclusion of uniform, high-quality data in international EOA databases.
调查观察者间对表型早发性共济失调(EOA)评估的一致性,并探讨共济失调评估与评分量表(SARA)是否能提供支持性标志物。
7名运动障碍专家对40例患者(平均年龄15岁[范围5 - 34岁];数据来源于格罗宁根大学医学中心1998 - 2012年的医疗记录)潜在的共济失调运动行为进行了独立的表型评估。我们通过Fleiss卡方检验确定观察者间的一致性。此外,我们比较了“明确”(至少六名观察者认可为原发性共济失调)和“混合”(认可为共济失调,但不符合“明确”标准)EOA表型之间SARA子评分的百分比([子评分/总分]×100%)。
表型EOA评估的一致性具有统计学意义(p<0.001),但强度中等(Fleiss卡方=0.45;95%可信区间0.38 - 0.51)。在疾病轻度进展期间,SARA步态子评分的百分比可区分“明确”和“混合”EOA表型。SARA步态子评分百分比>30%的患者中,原发性共济失调的出现频率高于子评分<30%的患者(p = 0.001)。
在来自不同学科的运动障碍专业人员中,观察者间对表型EOA识别的一致性强度有限。SARA步态子评分可在EOA表型之间提供支持性鉴别标志物。有望未来的表型见解将有助于在国际EOA数据库中纳入统一、高质量的数据。